Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanomaRANSON, Malcolm; HERSEY, Peter; BAKA, Sofia et al.Journal of clinical oncology. 2007, Vol 25, Num 18, pp 2540-2545, issn 0732-183X, 6 p.Article

Lomeguatrib, a potent inhibitor of O⁶-alkylguanine-DNA-alkyltransferase: Phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumorsRANSON, Malcolm; MIDDLETON, Mark R; MCELHINNEY, R. Stanley et al.Clinical cancer research. 2006, Vol 12, Num 5, pp 1577-1584, issn 1078-0432, 8 p.Article

A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancerKHAN, O. A; RANSON, M; MICHAEL, M et al.British journal of cancer. 2008, Vol 98, Num 10, pp 1614-1618, issn 0007-0920, 5 p.Article

Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumoursTAWBI, H. A; VILLARUZ, L; TARHINI, A et al.British journal of cancer. 2011, Vol 105, Num 6, pp 773-777, issn 0007-0920, 5 p.Article

A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancerSABHARWAL, A; CORRIE, P. G; MIDGLEY, R. S et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 5, pp 829-835, issn 0344-5704, 7 p.Article